OEC reports third quarter financials

Article

Production delays and merger costs contributed to a decrease in third quarter financial results for C-arm manufacturer OEC Medical Systems. The company saw revenues for the quarter (end-September) of $39 million, compared to $47.9 million in 1998, and a

Production delays and merger costs contributed to a decrease in third quarter financial results for C-arm manufacturer OEC Medical Systems. The company saw revenues for the quarter (end-September) of $39 million, compared to $47.9 million in 1998, and a net loss of $646,000, compared to net income of $4.3 million the year before. The Salt Lake City firm attributed the lower revenues to production delays for its Series 9800 line of digital mobile C-arms, introduced in June (SCAN 6/23/99). The series offers the only mobile C-arm available with a real-time 1K x 1K resolution, according to the company, and is designed for surgical applications that require advanced imaging capabilities.

Costs associated with the company’s planned merger with GE Medical Systems also contributed to OEC’s loss for the quarter. In August, OEC signed an agreement to merge with GEMS (SCAN 9/18/99). The company expects the deal to close on Nov. 29, following a special shareholder meeting to be held in Chicago.

Despite its disappointing third quarter results, OEC is ahead in revenues for the fiscal year, with nine-month sales at $142.3 million, compared to $135 million for the same period in 1998, a 5% increase.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.